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the objective of this study was to evaluate the performance of a new version of quantusFLM®, a 
software tool for prediction of neonatal respiratory morbidity (NRM) by ultrasound, which incorporates 
a fully automated fetal lung delineation based on Deep Learning techniques. A set of 790 fetal lung 
ultrasound images obtained at 24 + 0–38 + 6 weeks’ gestation was evaluated. Perinatal outcomes 
and the occurrence of NRM were recorded. quantusFLM® version 3.0 was applied to all images to 
automatically delineate the fetal lung and predict NRM risk. The test was compared with the same 
technology but using a manual delineation of the fetal lung, and with a scenario where only gestational 
age was available. The software predicted NRM with a sensitivity, specificity, and positive and negative 
predictive value of 71.0%, 94.7%, 67.9%, and 95.4%, respectively, with an accuracy of 91.5%. The 
accuracy for predicting NRM obtained with the same texture analysis but using a manual delineation of 
the lung was 90.3%, and using only gestational age was 75.6%. To sum up, automated and non-invasive 
software predicted NRM with a performance similar to that reported for tests based on amniotic fluid 
analysis and much greater than that of gestational age alone.
Neonatal Respiratory Morbidity (NRM) is the leading cause of mortality and morbidity associated with prema-
turity1–3. NRM can be assessed through Fetal Lung Maturity (FLM) estimation, helping to decide on the use of 
corticosteroids or plan place and time of elective delivery in late pregnancy complications4–8. Traditional clinical 
options for FLM estimation are either to use gestational age directly as a proxy FLM estimator or studying several 
components of the amniotic fluid9,10 through amniocentesis.
For decades, several approaches were attempted to estimate FLM non-invasively, involving direct image gray 
scale measurements11,12, lung tissue motion13,14 or the relation between lung and liver tissues,15 but none of these 
studies showed sufficient diagnostic accuracy for a real clinical use. More recently, quantitative texture analysis, 
a powerful technique to extract information from medical images and quantify tissue changes, was applied to 
the prediction of FLM16–18. Based on these principles, a non-invasive FLM estimator software (quantusFLM®, 
Transmural Biotech, Barcelona, Spain) was developed. This software has proven to have prediction accuracies 
similar to that of amniocentesis, first in single-center studies19,20 and recently in a large multi-center study with 
more than 700 deliveries21. Shortly after these first studies were published, the original technology behind quan-
tusFLM® was improved by incorporating Deep Learning techniques22, which have revolutionized image pro-
cessing in the last few years. This has resulted in a novel algorithm (i.e. version 3.0), designed to improve the 
prediction of NRM and to allow automatic identification and segmentation of the fetal lung, thereby avoiding the 
need for manual delineation as required in earlier versions of the software.
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In this study, we evaluated the performance of this new algorithm to predict NRM in a cohort of 790 fetuses 
where lung images were obtained within 48 hours of delivery and perinatal outcomes were recorded, at a gesta-
tional age range of 24 + 0–38 + 6 weeks’ gestation. In addition, we evaluated in the same cohort the predictive 
value of the same texture analysis algorithm but using a manual delineation of the fetal lung, and predictive per-
formance of gestational age alone.
Materials and Methods
patient recruitment and image acquisition protocol. A cohort of images (N = 730) from a previous 
multi-center study21 containing cases from 20 centers worldwide was used21. This set was further augmented with 
additional cases (N = 60) recruited at BCNatal (Hospital Clinic and Hospital Sant Joan de Deu, Barcelona) under 
the same protocol (2011/6291, 2013/8892) as the previous study.
Patients included in the study were receiving care in the participating institutions and enrolled either in a 
specific protocol for the evaluation of fetal lung maturity, in studies involving the use of fetal ultrasound or in 
studies where ultrasound was used as part of the clinical management approved by the local review boards. All 
patients included in the study gave written informed consent for the use of ultrasound images and perinatal data. 
All the methods hereby explained were performed in accordance with the relevant guidelines and regulations and 
approved, together with the study protocol, by the coordinator’s Institutional Review Board (Comité de ética de 
investigación clínica CEIC 2011/6291, 2013/8892).
A detailed description of the image acquisition protocol and definitions used of clinical outcomes is fully 
described in a previous study21. Briefly, eligible cases included pregnancies between 24 + 0 and 38 + 6 weeks of 
gestation in which an ultrasound was obtained within 48 h of delivery. Cases were considered non-eligible if corti-
costeroids were used for lung maturity between the image acquisition and delivery, when maternal BMI was ≥35 
and when fetuses had known congenital malformations. Neonates with conditions that could directly predispose 
or lead to NRM irrespective of lung maturity were also excluded.
Ultrasound images were obtained following a detailed acquisition protocol: an axial section of the fetal thorax 
at the level of the four-chamber cardiac view was magnified by adjusting only depth, but not the zoom option, 
until the thorax occupied about two thirds of the screen, avoiding obvious acoustic shadows from the fetal ribs 
(Fig. 1). The use of tissue harmonic imaging and adjustment of image settings such as gain, frequency and gain 
compensation were left to the discretion of the physician performing the ultrasound scan. All study images were 
inspected for image quality control and stored in the original Digital Imaging and Communication in Medicine 
(DICOM) format.
The primary clinical outcome of the study was NRM, including respiratory distress syndrome (RDS) or tran-
sient tachypnea of the newborn (TTN). Respiratory distress syndrome was defined based on clinical criteria 
including grunting, nasal flaring, tachypnea, chest wall retraction, and the need for supplemental oxygen together 
with typical chest radiography findings and admission to the neonatal intensive care unit for respiratory support2. 
TTN was diagnosed based on early respiratory distress (isolated tachypnea, rare grunting, minimal retraction) 
and a chest X-ray showing hyper-aeration of the lungs and prominent pulmonary vascular patterns23.
Gestational age was calculated for each patient based on the crown-rump length at first trimester ultrasound.
Image processing. DICOM images were processed using the new quantusFLM®, which automatically delin-
eated a region of interest (ROI) in the fetal lung and calculated a NRM risk score. The same set of 790 images 
was then analyzed using the same texture analysis algorithm as above but from a manual delineation of the ROI 
instead. The manual ROIs were delineated by an expert, using a Graphical User Interface (GUI) developed in 
MATLAB. An example of the ROIs used is shown in Fig. 1.
statistical analysis. Characteristics of the study population were described using mean and standard devi-
ation or number and percentage where appropriate. Missing information on main general variables such as race, 
baby gender, delivery mode, etc. were first tested using Missing Completely At Random (MCAR) via Little’s test24, 
and then blanks were filled using multiple imputation.
Figure 1. Example fetal lung ultrasound image and ROI marking the entire proximal lung.
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Automatic vs manual ROI delineation accuracy and reproducibility. In order to evaluate the accuracy of auto-
matic delineation of the fetal lung, automatically and manually delineated ROIs were compared using the most 
typical segmentation metric: pixel-to-pixel mean intersection over union. This metric measures the number of 
overlapping pixels between two ROIs as a percentage between 0 and 100, where 50% is usually considered the 
minimum satisfactory overlap percentage to call two ROIs “similar”. Furthermore, we evaluated the intra-observer 
reproducibility of manually delineated ROIs in a random sample of 100 images. Images were delineated twice by 
the same expert user and the area overlap was measured.
NRM prediction performance. To evaluate NRM prediction, output continuous NRM risk scores were binarized 
using the optimal cut-off point threshold, resulting in a dichotomic “high” or “low” NRM prediction. Optimal 
cut-off threshold was computed as that maximizing F1-Score using the entire dataset. F1-Score is an accuracy 
metric which measures the harmonic average between Sensitivity and Positive Predictive Value and is defined as 
(2*TP)/(2*TP + FP + FN). When prevalence is far from 50% as in NRM, F1-Score should be the preferred metric 
for measurement of overall performance25: instead of focusing equally on negatives and positives as standard 
Accuracy does, it balances Sensitivity and Positive Predictive Value to better judge the real usefulness of the 
prediction. From binarized NRM prediction, all classical performance indexes (Sensitivity, Specificity, etc.) were 
calculated at three different groups based on gestational age ([25.0–33.6], [34.0–38.6] and [34.0–36.6]).
Comparison of the performance among different methods. We compared the performance on NRM prediction 
of quantusFLM® (with automatic fetal lung delineation) against both if manual ROIs were used as input to quan-
tusFLM® instead and against a scenario where only gestational age was available. For fairness of comparison, 
optimal cut-off thresholds were computed independently in each case as those maximizing F1-Score using the 
entire dataset, as before. Apart from comparing NRM prediction performance, we performed McNemar’s Test26 
between the full proposed system and the other options (manual ROIs and gestational age alone), to establish 
quantitatively the statistical differences between the output predictions. Finally, for completeness, to establish if 
there was a relationship between performance and image quality, we evaluated performance on a subset of the 
images that were subjectively qualified as having ‘optimal image quality’ by the research team.
Results
Final dataset composition. Among the 790 pregnancies, there were 107 cases of NRM (13.5%) and 683 
controls. Table 1 shows the general clinical features of the study groups (see Supporting Information Tables S1 
-general characteristics-, S2 – perinatal and neonatal outcomes- and S3 – respiratory support and morbidity- for 
more in-depth analysis).
Automatic versus manual RoI delineation accuracy and reproducibility. Table 2 shows the accu-
racy and reproducibility of quantusFLM®’s automatic ROI delineation. Fig. 2 shows some visual examples com-
paring the automatic and manual ROIs. The automatic delineation reached 93% average overlap with expert’s 
manual ROIs, with only 1.5% of the ROIs falling below 50% overlap (12/790). In terms of reproducibility, while 
the automatic delineation ensures 100% (the ROI is always the same given the same image), experts changed on 
average 12% of the ROI pixels (reproducibility of 88%) on the subset of 100 images they delineated twice.
All (n = 790)
GA at scan
24.0–33.6 
(n = 174)
34.0–36.6 
(n = 197)
34.0–38.6 
(n = 616)
Maternal Age 31.7 (5.7) 31.7 (5.5) 31.4 (5.9) 31.7 (5.7)
Nulliparity 416 (52.7%) 88 (50.5%) 108 (54.8%) 328 (53.2%)
Multiple pregnancy 75 (8.9%) 25 (14.5%) 13 (6.5%) 50 (8.1%)
Maternal or fetal relevant conditions
 Preterm labor 49 (6.2%) 27 (15.5%) 18 (9.2%) 22 (3.5%)
 PPROM 158 (20%) 76 (43.7%) 64 (32.5%) 82 (13.3%)
 preeclampsia 124 (15.7%) 41 (23.6%) 39 (19.8%) 83 (13.5%)
 IUGR 148 (18.7%) 35 (20.1%) 35 (17.8%) 113 (18.3%)
Gestational Age at delivery (weeks) 36.0 (2.6) 31.4 (2.2) 35.5 (0.7) 37.2 (1.2)
Mode of delivery
 Spontaneous vaginal delivery 315 (39.9%) 54 (31.0%) 88 (44.7%) 261 (42.4%)
 Elective cesarean section 279 (35.3%) 75 (43.1%) 61 (31.0%) 204 (33.1%)
Birthweight (g) 2517 (755) 1554 (483) 2368 (445) 2787 (576)
Corticosteroid administered 225 (28%) 146 (84%) 59 (30%) 79 (12.8%)
Lapse between last steroid dose and 
scan (days) 9.9 (15.4) 6.2 (11.4) 12.6 (17.4) 16.6 (19.2)
NICU admission 247 (31.2%) 152 (87.4%) 71 (36.0%) 95 (15.4%)
Neonatal Respiratory Morbidity 107 (13.5%) 72 (41.3%) 31 (15.7%) 35 (5.6%)
Table 1. General characteristics of the study population. Mean (SD) or n (%) when appropriate. PPROM: 
preterm premature rupture of membranes. IUGR: intrauterine growth restriction. NICU: neonatal intensive 
care unit.GA, gestational age.
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NRM prediction performance. Table 3 shows the performance of the three approaches used. Using 
F1-Score as main reference, texture analysis on automatically and manually delineated ROIs resulted in scores 
of 69.4% and 65.5% respectively. GA alone (optimal cut-off point at GA <= 35.5) resulted in a score of 49.6%. 
McNemar’s Test result between manual and automatic NRM predictions was p = 0.07, indicating some similarity. 
McNemar’s Test between texture analysis by either method and GA alone was p < 0.01, indicating a statistical 
difference between them.
F-1 score in the subset of 372 images (47% of the data) which were considered as having “optimal image qual-
ity” by the research team was 71.3%, only 1.9% higher than on the full set.
Discussion
In this study we evaluated an improved version of existing commercial software for NRM prediction, which 
now includes an automatic delineation of the fetal lung and novel Deep Learning ultrasound image processing 
techniques. The results showed that automatic delineation of the fetal lung was as reliable as manual delineation, 
with the advantage of improved repeatability. The predictive performance of the software achieved results that 
improved those reported for previous versions of the same technology. Finally, the results illustrate that a com-
puter assisted method improves significantly the prediction of NRM as based merely on gestational age.
Results of this study suggest that the automated delineation method achieved similar or slightly better pre-
diction rates in relation with the reported performance in a very similar population for the previous version of 
Automatic delineation ACCURACY (compared with expert’ ROIs)
Overlap average 93% (std = 4.5%)
Number of Images with overlap <50% 12 (1.5%)
REPRODUCIBILITY (comparison with itself)
AUTOMATIC MANUAL
Overlap average 100% (0%) 88% (std = 2.0%)
Number of Images with overlap <50% 0 (0%) 0 (0%)
Table 2. Automatic vs manual fetal lung ROI delineation accuracy and reproducibility. Mean (SD) or n (%) 
where appropriate.
Figure 2. Example automatic ROI segmentation of test images. Top 2 rows: regular success cases. Bottom 
row: example “failure” cases. The automatic segmentation extracts the fetal lung correctly in all test images 
and ensures 100% reproducibility of results given same image. Even when it disagrees with human ROIs it is 
delineating fetal lung and not another organ.
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quantusFLM®21. In the overall population evaluated, results showed improvements by about 5% in accuracy and 
9% in F1-score, and in the 34.0–38.6 age range, accuracy was higher by 5% and F-1 score was higher by 17% in 
comparison with previously reported data. Moreover, although a direct comparison was not performed, the data 
again points towards similar or better prediction performance of quantusFLM® as compared with laboratory 
methods in amniotic fluid27–32, see Supporting Information Table S4. The best performing method, Lecithin/
sphingomyelin ratio, has a reported accuracy 10% lower (81.6% compared to 91.7%) and a 22.6% lower F1-Score 
(46.8% compared to 69.4%). In addition, direct comparison with the use of gestational age alone as a predictor 
of the risk of NRM showed a remarkable improvement. Accuracy was improved by 16% and F-1 score by 19.8%. 
Finally, the similar performance observed in optimal and suboptimal quality images suggests that the system is 
robust to perform well in real conditions.
The software evaluated in this study introduced a fully-automated delineation of the fetal lung, thereby avoid-
ing the need for manual delineation as required in earlier versions of the software19–21. The comparison between 
manual and automatic segmentation demonstrated that automatic delineation did not reduce the predictive per-
formance of the software. Automatic medical ultrasound image segmentation has been widely studied33,34, with 
notable success examples such as prostate35 or breast cancer images36. Segmentation of fetal ultrasound images 
has also been studied, mostly as a tool for the automatic evaluation of fetal biometries, estimating structures such 
as abdomen, head, femur or the whole fetus37,38. Yet, as far as we know, this is the first study reporting reliable fetal 
lung segmentation from ultrasound images.
From a clinical perspective, the use of a noninvasive test for FLM can be particularly relevant in late preterm 
deliveries, which represent 5–10% of pregnancies in most healthcare systems. As far as around 23% of cases 
of late preterm deliveries did not have a clear indication or were delivered after a non-evidence based indica-
tion39,40. Reliable information about the risks of NRM might be crucial to plan the place and timing of delivery. 
Furthermore, this information would assist in the decision of using antenatal corticosteroids. As recently shown 
in a randomized trial, antenatal corticosteroids reduced by about 20% the risk of NRM in late-preterm deliver-
ies8. Considering the prevalence of late-preterm delivery, this small benefit might represent thousands of cases 
yearly and a remarkable fraction of neonatal health-care costs. Thus, a strong reason against the generalized use 
of corticosteroids in late-preterm pregnancies is that a modest benefit should be weighed against the poten-
tially important risks of corticosteroids in neurodevelopment and fetal metabolic programming41–43. Therefore, 
efforts have to be raised not to overuse them in cases which do not meet the strict criteria of the study published 
by Gyamfi-Bannerman et al.8,44. Furthermore, the balance between benefits and risks has to be evaluated when 
repeated doses long after an initial dose are considered or if an early term elective cesarean delivery is planned45. 
A noninvasive technique for predicting FLM might select patients eligible for the administration of corticoster-
oids late in pregnancy. In addition, a non-invasive technique would avoid the fear and discomfort of amniocen-
tesis, which has been another reason commonly given for not evaluating FLM by classical methods in amniotic 
fluid. Thus, a non-invasive tool to determine the individual risk of each baby to develop NRM would allow a 
selective use of corticosteroids in this context. Otherwise, with a systematic administration policy, almost 90% 
of late-preterm deliveries would receive corticosteroids unnecessarily. On another hand, a remarkable fraction 
of newborns will effectively suffer from NRM despite corticosteroid administration. In this study for example, 
corticosteroids were administered to 71% of fetuses that ended up having NRM anyway (76/107). Predicting 
this risk might allow a better planning of strategies of neonatal support. Thus, the use of a non-invasive tool that 
individualizes the risk of NRM would allow selecting cases for corticosteroid administration, while identifying 
a high-risk group that could develop NRM despite the use of corticosteroids. Finally, it would be interesting 
to study if this tool can be used to detect changes in the fetal lung after steroid administration. However, we 
quantusFLM® quantusFLM® from manual ROIs Using GA only
All 24.0–33.6 34.0–36.6 34.0–38.6 All 24.0–33.6 34.0–36.6 34.0–38.6 All 24.0–33.6 34.0–36.6 34.0–38.6
N 790 174 197 616 790 174 197 616 790 174 197 616
NRM 107 (13.5%) 72 (41.4%) 31 (15.7%) 35 (5.7%) 107 (13.5%) 72 (41.4%) 31 (15.7%) 35 (5.7%) 107 (13.5%) 72 (41.4%) 31 (15.7%) 35 (5.7%)
SENS 71.0% (76/107)
75.0% 
(54/72)
64.5% 
(20/31)
62.9% 
(22/35)
68.2% 
(73/107)
76.4% 
(55/72)
51.6% 
(16/31)
51.4% 
(18/35)
88.8% 
(95/107)
100.0% 
(72/72)
74.2% 
(23/31)
65.7% 
(23/35)
SPEC 94.7% (647/683)
87.3% 
(89/102)
88.6% 
(147/166)
96.0% 
(558/581)
93.7% 
(640/683)
86.3% 
(88/102)
84.9% 
(141/166)
95.0% 
(552/581)
73.5% 
(502/683)
0.0% 
(0/102)
52.4% 
(87/166)
86.4% 
(502/581)
PPV 67.9% (76/112)
80.6% 
(54/67)
51.3% 
(20/39)
48.9% 
(22/45)
62.9% 
(73/116)
79.7% 
(55/69)
39.0% 
(16/41)
38.3% 
(18/47)
34.4% 
(95/276)
41.4% 
(72/174)
22.5% 
(23/102)
22.5% 
(23/102)
NPV 95.4% (647/678)
83.2% 
(89/107)
93.0% 
(147/158)
97.7% 
(558/571)
95.0% 
(640/674)
83.8% 
(88/105)
90.4% 
(141/156)
97.0% 
(552/569)
97.7% 
(502/514) 0.0% (0/0)
91.6% 
(87/95)
97.7% 
(502/514)
ACC 91.5% (723/790)
82.2% 
(143/174)
84.8% 
(167/197)
94.2% 
(580/616)
90.3% 
(713/790)
82.2% 
(143/174)
79.7% 
(157/197)
92.5% 
(570/616)
75.6% 
(597/790)
41.4% 
(72/174)
55.8% 
(110/197)
85.2% 
(525/616)
F1- Score 69.4% (152/219)
77.7% 
(108/139)
57.1% 
(40/70)
55.0% 
(44/80)
65.5% 
(146/223)
78.0% 
(110/141)
44.4% 
(32/72)
43.9% 
(36/82)
49.6% 
(190/383)
58.5% 
(144/246)
34.6% 
(46/133)
33.6% 
(46/137)
LR+ 13.5 5.9 5.6 15.9 10.8 5.6 3.4 10.3 3.4 1.0 1.6 4.8
LR- 0.3 0.3 0.4 0.4 0.3 0.3 0.6 0.5 0.2 0.0 0.5 0.4
Table 3. Performance on NRM prediction. NRM = Neonatal Respiratory Morbidity; SENS = Sensitivity, 
SPEC = Specificity;PPV = Positive Predictive Value; NPV = Negative Predictive Value; ACC = Accuracy; 
LR+ = Positive Likelihood Ratio; LR- = Negative Likelihood Ratio.
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believe this is something that needs to be addressed appropriately in a separate, well focused study. Since it can be 
assumed that changes in FLM occur progressively after steroid administration, it is plausible to think that changes 
in texture parameters may not be detectable until a particular threshold and we currently do not know how close 
to the steroids administration these changes might be detected. This would need to be studied.
This study has strengths and limitations. Images were collected at multiple centers around the world using 
different machines and leaving configuration in the hands of each technician, therefore mimicking real clinical 
conditions. The final dataset statistics are consistent with those of the previous study21 but with the addition of 
60 patients, 50 of which were late pre-term and early-term, which allowed to better assess the performance of 
the software in this specific group. In this study we addressed a common criticism that systems for predicting 
NRM should be compared with the performance of gestational age alone. Among the limitations of this study, 
the rate of NRM in the preterm group was around 15% which is a higher rate compared to the one described in 
other studies2. In addition, we acknowledge that although the results suggest a clear improvement in relation 
with the published performance of methods based on amniotic fluid analysis, a direct comparison on the same 
patients was not undertaken. Finally, the method tested in this study uses an indirect approach to estimate lung 
maturity. By definition, prenatal prediction of NRM is hampered by the fact that the outcome is largely, but not 
exclusively, determined by the fetal lung maturity status. Thus, in circumstances such as neonatal sepsis, malfor-
mations potentially affecting lung function or intrapartum hypoxic-ischemic events, newborns with normal lung 
maturity in utero may present respiratory impairment. Also, specific conditions such as fetal growth restriction, 
multiple pregnancy, diabetes or premature rupture of membranes were not analyzed separately. Differences in the 
performance of quantusFLM® in these subgroups cannot be excluded and requires further research.
To conclude, a software system incorporating Deep Learning techniques improved the prediction of NRM and 
allowed automatic identification and segmentation of the fetal lung, thereby simplifying clinical use. Noninvasive 
assessment of FLM would allow selecting patients at high risk of NRM among late preterm deliveries, in order to 
maximize benefits and minimize the risks of antenatal corticosteroids administration and to improve planning 
of the place and timing of delivery. While the findings here reported confirm and expand previous studies and 
strongly support the use of noninvasive techniques for the prediction of NRM in the clinical setting, further stud-
ies confirming these results are strongly required.
Data Availability
The dataset generated and analysed during the current study is not publicly available due to restrictions according 
to patient privacy regulations, but are available from the corresponding author on reasonable request.
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